99 related articles for article (PubMed ID: 11697319)
1. [Do advances in molecular biology change indications for adjuvant chemotherapy in colorectal cancer?].
Roque I; Michel P
Gastroenterol Clin Biol; 2001; 25(8-9):837-8. PubMed ID: 11697319
[No Abstract] [Full Text] [Related]
2. [Colon cancer: what is new in 2004?].
André T; Louvet C; de Gramont A
Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant chemotherapy for colon cancer].
Dahl O
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability in colon cancer.
Jimenez JJ; Blanes A; Diaz-Cano SJ
N Engl J Med; 2003 Oct; 349(18):1774-6; author reply 1774-6. PubMed ID: 14593998
[No Abstract] [Full Text] [Related]
5. Advances in the adjuvant treatment of colorectal cancer.
Nordman IC; Iyer S; Joshua AM; Clarke SJ
ANZ J Surg; 2006 May; 76(5):373-80. PubMed ID: 16768699
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients.
Watanabe T; Kanazawa T; Kazama Y; Tanaka J; Tanaka T; Ishihara S; Nagawa H
J Clin Oncol; 2005 Dec; 23(35):9031-2; author reply 9032-3. PubMed ID: 16339756
[No Abstract] [Full Text] [Related]
7. Colorectal cancer.
Yip D
Med J Aust; 1999 Mar; 170(6):283; author reply 284. PubMed ID: 10212654
[No Abstract] [Full Text] [Related]
8. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
9. [Position of adjuvant and palliative chemotherapy in colonic cancer treatment].
Louvet C
Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S255-64. PubMed ID: 9762262
[No Abstract] [Full Text] [Related]
10. Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.
Graziano F; Catalano V; Baldelli AM; Cascinu S
Expert Rev Anticancer Ther; 2001 Aug; 1(2):247-57. PubMed ID: 12113030
[TBL] [Abstract][Full Text] [Related]
11. The implications of colorectal cancer molecular biology in clinical practice.
Kargozaran H; Kahlenberg M; Khatri VP
Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
[TBL] [Abstract][Full Text] [Related]
12. Target practice: figuring out which, when, and why to use systemic therapies for metastatic colon cancer.
Holen KD
Cancer Invest; 2006 Feb; 24(1):98-105. PubMed ID: 16466998
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for colon cancer: evidence on improvement in survival.
Samantas E; Dervenis C; Rigatos SK
Dig Dis; 2007; 25(1):67-75. PubMed ID: 17384510
[TBL] [Abstract][Full Text] [Related]
14. Re: Pooled analysis of fluorouracil-based adjuvant therapy of stage II and III colon cancer: who benefits and by how much?
Elsaleh H; Iacopetta B
J Clin Oncol; 2005 Jan; 23(3):653-4; author reply 654-5. PubMed ID: 15659520
[No Abstract] [Full Text] [Related]
15. [Multimodal therapy in colon carcinoma].
Seufferlein T; Lutz MP; Adler G
Internist (Berl); 2003 Mar; 44(3):322-30, 332-5. PubMed ID: 12731419
[No Abstract] [Full Text] [Related]
16. [Efficacy of postoperative adjuvant chemotherapy for colorectal cancer].
Nozoe Y; Ogata Y; Miyagi Y; Nakagawa M; Matono K; Sasatomi T; Araki Y; Shirouzu K
Gan To Kagaku Ryoho; 2002 Jan; 29(1):67-72. PubMed ID: 11816480
[TBL] [Abstract][Full Text] [Related]
17. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for colorectal cancer.
Maughan TS
Br J Cancer; 2001 Nov; 85(10):1422-4. PubMed ID: 11720422
[No Abstract] [Full Text] [Related]
19. No clear evidence for adjuvant therapy in people with stage II colon cancer.
Wille-Jørgensen P
Cancer Treat Rev; 2005 Apr; 31(2):147-50. PubMed ID: 15847983
[No Abstract] [Full Text] [Related]
20. Adjuvant therapy for colon cancer: present and perspectives.
De Dosso S; Sessa C; Saletti P
Cancer Treat Rev; 2009 Apr; 35(2):160-6. PubMed ID: 19013023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
